Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 16, 2016 17:16 ET | Source: Depomed, Inc

Depomed Receives Request to Call Special Meeting of Shareholders

NEWARK, Calif., Sept. 16, 2016 (GLOBE NEWSWIRE) -- Depomed, Inc. (NASDAQ:DEPO) (“Depomed” or the “Company”) today announced that Starboard Value LP (together with its affiliates, “Starboard”) has...
September 08, 2016 08:00 ET | Source: Depomed, Inc

Data from Depomed’s Highly-Differentiated Pain and CNS-Focused Product Portfolio Presented at PAINWeek 2016

NEWARK, Calif., Sept. 08, 2016 (GLOBE NEWSWIRE) -- Depomed, Inc. (NASDAQ:DEPO) announced today the presentation of clinical data from 10 trials and studies involving NUCYNTA® ER, Gralise® Lazanda®...
September 07, 2016 08:00 ET | Source: Depomed, Inc

Depomed to Present at the Morgan Stanley Global Healthcare Conference

NEWARK, Calif., Sept. 07, 2016 (GLOBE NEWSWIRE) -- Depomed, Inc. (NASDAQ:DEPO) today announced that it will participate in a fireside chat at the 2016 Morgan Stanley Global Healthcare Conference...
September 06, 2016 08:00 ET | Source: Depomed, Inc

Depomed Announces Presentations at PAINWeek 2016

NEWARK, Calif., Sept. 06, 2016 (GLOBE NEWSWIRE) -- Depomed, Inc. (NASDAQ:DEPO) announced today the presentation of ten abstracts at PAINWeek® 2016, the nation's largest annual meeting for frontline...
August 03, 2016 16:01 ET | Source: Depomed, Inc

Depomed Reports Second Quarter 2016 Financial Results

- Second Quarter Revenues of $117 million, 23% over 2Q 2015 -- NUCYNTA® Franchise Second Quarter 2016 Record Net Sales of $72 million, 27% over 2Q 2015 -- Conference Call Scheduled for Today at 4:30...
July 27, 2016 16:05 ET | Source: Depomed, Inc

Depomed to Report Second Quarter Fiscal Year 2016 Financial Results on Wednesday, August 3, 2016

NEWARK, Calif., July 27, 2016 (GLOBE NEWSWIRE) -- Depomed, Inc. (NASDAQ:DEPO) today announced that it will release second quarter fiscal year 2016 financial results after the close of market,...
July 06, 2016 08:00 ET | Source: Depomed, Inc

Depomed to Present at the Cantor Fitzgerald Healthcare Conference

NEWARK, Calif., July 06, 2016 (GLOBE NEWSWIRE) -- Depomed, Inc. (NASDAQ:DEPO) today announced its participation at Cantor Fitzgerald’s 2nd Annual Healthcare Conference in New York, New York. ...
June 23, 2016 16:05 ET | Source: Depomed, Inc

Depomed Proposes to Call Special Meeting of Shareholders on October 28, 2016 Following Outcome of NUCYNTA Patent Litigation

NEWARK, Calif., June 23, 2016 (GLOBE NEWSWIRE) -- Depomed, Inc. (NASDAQ:DEPO) today announced that, in response to a second record date request by Starboard Value LP, it has set a record date of...
June 14, 2016 16:00 ET | Source: Depomed, Inc

Depomed to Present at the JMP Securities Life Sciences Conference

NEWARK, Calif., June 14, 2016 (GLOBE NEWSWIRE) -- Depomed, Inc. (NASDAQ:DEPO) today announced that it will be presenting at the JMP Securities 2016 Life Sciences Conference in New York, New York....
May 26, 2016 11:17 ET | Source: Assertio Therapeutics, Inc.

Depomed Issues Statement in Response to Starboard’s Press Release

NEWARK, Calif., May 26, 2016 (GLOBE NEWSWIRE) -- Depomed, Inc. (NASDAQ:DEPO) ("Depomed" or the "Company") today issued the following statement in response to Starboard Value LP’s (“Starboard”)...